This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Ottawa directory, so their publications, courses and email address may be missing. Find their university profile.
Latest funding
- $20,000
Targeting vascular INflammation in patients with Community-Acquired Pneumonia (TIN-CAP)
CIHR · 2023 · Co-investigator
- $504,900
The Canadian Study of Arterial Inflammation in Patients with Diabetes and Recent Vascular Events: EvaluatioN of Canakinumab Effectiveness (CADENCE)
CIHR · 2018 · Principal investigator
Targeting vascular INflammation in patients with Community-Acquired Pneumonia (TIN-CAP)
Principal investigators: Boczar, Kevin E; Beanlands, Rob; Corrales-Medina, Vicente F; Rayner, Katey
Keywords: Coronary Artery Disease; Fdg-Pet/Ct; Icosapent Ethyl; Inflammation; Pneumonia
The Canadian Study of Arterial Inflammation in Patients with Diabetes and Recent Vascular Events: EvaluatioN of Canakinumab Effectiveness (CADENCE)
Principal investigators: Beanlands, Rob; Raggi, Paolo
Keywords: Atherosclerosis; Biomarkers; Canakinumab; Cardiovascular Disease; Diabetes; Imaging; Inflammation; Pet
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.